DIABETES INCIDENCE STUDY IN SWEDEN, DISS

DIABETES INCIDENCE STUDY IN SWEDEN, DISS Scientific publications published, in press or accepted for publication in international peer-reviewed journals (English) 1986 1. Östman J, Arnqvist HJ, Blohmé G, Lithner F, Littorin B, Nyström L, Sandström A, Scherstén B, Wall S, Wibell L. Epidemiology of diabetes mellitus in Sweden. Results of the first year of a prospective study in the population age group 15-34 years. Acta Medico Scandinavia 1986;220(5):437-45 1992 2. Blohmé G, Nyström L, Arnqvist HJ, Lithner F, Littorin B, Olsson PO, Scherstén B, Wibell L, Östman J. Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adults: results from a 5-year prospective nationwide study of the 15-34-year age group in Sweden [published erratum appears in Diabetologia 1992;35:296]. Diabetologia 1992;35(1):56-62 3. Landin-Olsson M, Palmer JP, Lernmark Å, Blom L, Sundkvist G, Nyström L, Dahlquist G. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia 1992;35(11):1068-73 4. Olsson-Landin M, Karlsson FA, Lernmark Å, Sundkvist G, and the Diabetes Incidence Study in Sweden Group. Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes 1992;41:1022-7 5. Nyström L, Dahlquist G, Östman J, Wall S, Arnqvist H, Blohmé G, Lithner F, Scherstén B, Wibell L. Risk of developing insulin-dependent diabetes mellitus (IDDM) before 35 years of age: indications of climatological determinants for age at onset. International Journal of Epidemiology 1992;21(2):352-8 6. Nyström L, Östman J, Wall S, Wibell L. Mortality of all incident cases of diabetes mellitus in Sweden diagnosed 1983-1987 at age 15-34 years. Diabetes Incidence Study in Sweden (DISS) Group. Diabetic Medicine 1992;9(5):422-7 1993 7. Arnqvist HJ, Littorin B, Nyström L, Scherstén B, Östman J, Blohmé G, Lithner F, Wibell L. Difficulties in classifying diabetes at presentation in the young adult. Diabetic Medicine 1993;10(7):606-13 1996 8. Jonsson PM, Nyström L, Rosenqvist U, Sterky G, Wall S, Östman J. Diabetes mellitus and health service utilisation: a case-control study of outpatient visits 8 years after diagnosis. Diabetic Medicine 1996;13(12):1056-63 9. Kockum I, Lernmark Å, Dahlquist G, Falorni A, Hagopian WA, Landin-Olsson M, Li LC, Luthman H, Palmer JP, Sanjeevi CB, Sundkvist G, Östman J. Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. The Swedish Childhood Diabetes Study Group and The Diabetes Incidence in Sweden Study (DISS) Group. Hormone and Metabolic Research 1996;28(7):344-7 10. Kockum I, Lernmark A, Dahlquist G, Falorni A, Hagopian WA, Landin-Olsson M, Li LC, Luthman H, Palmer JP, Sanjeevi CB, Sundkvist G, Östman IJ. Hormone and Metabolic Research 1996;28(7):344-7 11. Littorin B, Sundkvist G, Scherstén B, Nyström L, Arnqvist HJ, Blohmé G, Lithner F, Wibell L, Östman J. Patient administrative system as a tool to validate the ascertainment in the diabetes incidence study in Sweden (DISS). Diabetes Research in

Clinical Practice 1996;33(2):129-33 12. Östman J, Lernmark A, Landin-Olsson M, Sundkvist G, Palmer J, Arnqvist H, Blohmé G, Lithner F, Littorin B, Nyström L, Scherstén B, Wibell L. Autoimmune (type 1) diabetes in young adults in Sweden. Hormone and Metabolic Research 1996;28(7):348-50 1997 13. Lotfi K, Sund G, Lowe R, Graham J, Landin-Olsson M, Kockum I, Deeb S, Lernmark Å. The beta cell glucokinase promoter variant is an unlikely risk factor for diabetes mellitus. Diabetes Incidence Study in Sweden (DISS). Diabetologia 1997;40(8):959-62 1998 14. Schranz DB, Bekris L, Landin-Olsson M, Törn C, Niläng A, Toll A, Grönlund H, Toivola B, Lernmark Å. A simple and rapid microsepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS). Journal of Immunological Methods 1998;213(1):87-97 1999 15. Graham J, Kockum I, Sanjeevi CB, Landin-Olsson M, Nyström L, Sundkvist G, Arnqvist H, Blohmé G, Lithner F, Littorin B, Scherstén B, Wibell L, Östman J, Lernmark Å, Breslow N. Negative association between type 1 diabetes and HLA DQB1*0602- DQA1*0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group. European Journal of Immunogenetics 1999;26(2-3):117-27 16. Landin-Olsson M, Arnqvist HJ, Blohmé G, Littorin B, Lithner F, Nyström L, Scherstén B, Sundkvist G, Wibell L, Östman J. Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus. Autoimmunity 1999;29(1):57-63 17. Littorin B,Sundkvist G, Hagopian W, Landin-Olsson M, Lernmark Å, Östman J, Arnqvist HJ, Blohmé G, Bolinder J, Eriksson JW, Lithner F, Scherstén B, Wibell L. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labelled as type 2 or unclassifiable diabetes. Diabetes Care 1999;22(3):409-12 2000 18. Jonsson PM, Marké L, Nyström L, Wall S, Östman J. Excess costs of medical care 1 and 8 years after diagnosis of diabetes: estimates from young and middle-aged incidence cohorts in Sweden. Diabetes Research in Clinical Practice 2000;50(1):35-47 19. Schranz DB, Bekris L, Landin-Olsson M, Törn C, Niläng A, Toll A, Sjöström J, Grönlund H, Lermnark Å. Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies. Diabetes Incidence Study in Sweden (DISS). Hormone and Metabolic Research 2000;32(4):133-8 20. Törn C, Landin-Olsson M, Lernmark Å, Palmer JP, Arnqvist HJ, Blohmé G, Lithner F, Littorin B, Nyström L, Scherstén B, Sundkvist G, Wibell L, Östman J. Prognostic factors for the course of β cell function in autoimmune diabetes. Journal of Clinical Endocrinology and Metabolism 2000;85(12):4619-23 21. Törn C, Landin-Olsson M, Östman J, Scherstén B, Arnqvist H, Blohmé G, Björk E, Bolinder J, Eriksson J, Littorin B, Nyström L, Sundkvist G, Lernmark Å. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds. Diabetes Metabolism Research Review 2000;16(6):442-7 22. Östman J, Landin-Olsson M, Törn C, Palmer J, Lernmark A, Arnqvist H, Björk E,

Bolinder J, Blohmé G, Eriksson J, Littorin B, Nyström L, Scherstén B, Sundkvist G, Wibell L. Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus - a nationwide study. Diabetic Medicine 2000;17(4):269-74 2001 23. Jonsson PM, Nyström L, Sterky G, Wall S. Socio-demographic predictors of self-rated health in patients with diabetes of short duration. Scandinavian Journal of Public Health 2001;29(4):263-70 24. Littorin B, Sundkvist G, Nyström L, Carlsson A, Landin-Olsson M, Östman J, Arnqvist HJ, Björk E, Blohmé G, Bolinder J, Eriksson JW, Scherstén B, Wibell L. Family characteristics and life events prior to the onset of autoimmune type 1 diabetes in young adults: A nationwide study. Diabetes Care 2001;24(6):1033-7 25. Törn C, Landin-Olsson M, Lernmark Å, Scherstén B, Östman J, Arnqvist HJ, Björk E, Blohmé G, Bolinder J, Eriksson J, Littorin B, Nyström L, Sundkvist G. Combinations of beta cell specific autoantibodies at diagnosis of diabetes reflects different courses of beta cell damage. Autoimmunity 2001;33(2):115-20 26. Törn C, Landin-Olsson M, Scherstén B. Predictability of C-peptide for autoimmune diabetes in young adult diabetic patients. Pracical Diabetes International 2001;18(3):83-8 27. Wibell L, Nyström L, Östman J, Arnqvist H, Blohmé G, Lithner F, Littorin B, Sundkvist G. Increased mortality in diabetes during the first 10 years of the disease. A population-based study (DISS) in Swedish adults 15-34 years old at diagnosis. Journal of Internal Medicine 2001;249(3):263-70 2002 28. Pundziute-Lyckå A, Dahlquist G, Nyström L, Arnqvist H, Björk E, Blohmé G, Bolinder J, Eriksson J, Ohlson L-O, Sundkvist G, Östman J and the Swedish Childhood Diabetes Study Group. The incidence of Type 1 diabetes has not increased but shifted to younger age at diagnosis in the 0-34 years group in Sweden 1983 to 1998. Diabetologia 2002;45(6):783-91 2003 29. Borg H, Arnqvist H, Björk E, Bolinder J, Eriksson JW, Nyström L, Jeppsson J-O, Sundkvist G. Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS). Diabetologia 2003;46(2):173-81 30. Elfving AM, Lindberg BA, Nyström L, Sundkvist G, Lernmark Å, Ivarsson SA. Islet autoantibodies in cord blood from patients who developed type 1 diabetes mellitus at 15-30 years of age. Autoimmunity 2003;36(4):227-31 31. Henricsson M, Nyström L, Blohmé G, Östman J, Kullberg C, Svensson M, Schölin A, Arnqvist H, Björk E, Bolinder J, Eriksson JW, Sundkvist G. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003;26(2):349-54 32. Littorin B, Nyström L, Gullberg B, Råstam L, Östman J, Arnqvist H, Björk E, Blohmé G, Bolinder J, Eriksson JW, Scherstén B, Sundkvist G. Increasing body mass index at diagnosis of diabetes in young adult people during 1983-1999 in the Diabetes Incidence Study in Sweden (DISS). Journal of Internal Medicine 2003; 254(3):251-6 33. Svensson M, Sundkvist G, Arnqvist H, Björk E, Blohmé G, Bolinder J, Henricsson M, Nyström L, Torffvit O, Waernbaum I, Östman J, Eriksson JW. Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management:

Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003;26(10):2903-9 2004 34. Kyvik KO, Nyström L, Gorus F, Songini M, Östman J, Castell C, Green A, Guyrus E, Ionescu-Tirgoviste C, McKinney PA, Michalkova D, Ostrauskas R, Raymond NT. The epidemiology of Type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 2004;47(3):377-84 35. Schölin A, Björklund L, Borg H, Arnqvist H, Björk E, Blohmé G, Bolinder J, Eriksson JW, Gudbjörnsdottir S, Nyström L, Östman J, Karlsson AF, Sundkvist G. Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults: A prospective follow-up of the nationwide Diabetes Incidence Study in Sweden (DISS). Journal of Internal Medicine 2004;255(3):384-91 36. Schölin A, Törn C, Nyström L, Berne C, Arnqvist H, Blohmé G, Bolinder J, Eriksson JW, Kockum I, Landin-Olsson M, Östman J, Karlsson FA, Sundkvist G, Björk E. Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in type 1 diabetes. Diabetic Medicine 2004;21(5):445-55 2005 37. Bolinder J, Fernlund J, Borg H, Arnqvist H, Björk E, Blohmé G, Eriksson JW, Nyström L, Sundkvist G, Östman J. Hyperproinsulinemia segregates young adult patients with newly-diagnosed anutoimmune (type 1) and non-autoimmune (type 2) diabetes. Scandinavian Journal of Clinical Investigation 2005;65:585-94 38. Dahlquist GG, Pundziuté A, Nyström L on behalf of the Swedish Childhood Diabetes Study and the Diabetes Incidence Study in Sweden (DISS) Groups. Birth weight and risk for type 1 diabetes occurring in children and young adults: a population-based register study. Diabetologia 2005;48:114-7 39. Valdes AM, Thomson G, Graham J, Zarghami M, McNeney B, Kockum I, Smith A, Lathrop M, Steenkiste AR, Dorman JS, Noble AJ, Hansen JA, Publiese A, Lernmark Å, Swedish childhood Study Group, Diabetes Incidence in Sweden Study Group. D6S265*15 marks a DRB1*15, DQB1*0602 Haplotype associate with attenuated protection from type 1 diabetes mellitus. Diabetologia 2005;48:2540-3 40. Åkesson K, Nyström L, Östman J, Lernmark Å, Kockum I and the DISS study group. Sexual dimorphism in the risk for developing insulin treated diabetes among relatives to diabetes patients diagnosed between 15 and 34 years of age. Diabetes Medicine 2005;22:1551-7 2006 41. Bakhtadze E, Borg H, Stenström G, Fernlund P, Arnqvist H, Ekbom-Schnell A, Bolinder J, Eriksson JW, Gudbjörnsdottir, Nyström L, Groop L, Sundkvist G. HLA- DQB1 genotypes, islet antibodies and beta-cell function in the classification of recent onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden. Diabetologia 2006;49:1785-94 42. Littorin B, Blom P, Schölin A, Arnqvist H, Blohmé G, Bolinder J, Ekbom Schnell A, Eriksson JW, Gudbjörnsdottir S, Nyström L, Östman J, Sundkvist G. Low plasma 25- hydroxyvitamin D levels in type 1 diabetes among young adults. Results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 49;2847-52 43. Svensson M, Nyström L, Schön S, Dahlquist G on behalf of the Swedish Childhood Diabetes Study and the Swedish Registry for Active Treatment of uraemia. Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease. A nationwide population-based study. Diabetes Care 2006;29(3):538-42 44. Waernbaum I, Blohmé G, Östman J, Sundkvist G, Eriksson JW, Arnqvist H, Björk E, Bolinder J, Nyström L. Excess mortality in incident cases of diabetes mellitus aged

15-34 years at diagnosis. A population-based study (DISS) in Sweden. Diabetologia 2006;49(4):653-9 45. Åkesson K, Nyström L, Östman J, Lernmark Å, Kockum I and the DISS study group. Sexual dimorphism in the risk for developing insulin treated diabetes among relatives to diabetes patients diagnosed between 15 and 34 years of age. Diabetic Medicine 2005;22:1551-7 2007 46. Fawwaz S, Nikamo P, Törn C, Landin-Olsson M, Lernmark Å, Alarcón-Riquelme M, Kockum I and the Diabetes Incidence in Sweden Study Group. Diabetic Medicine 2007;24:1473-7 47. Jensen RA, Gilliam LK, Törn C, Landin-Olsson M, Karlsson FA, Palmer JP, Kockum I, Åkesson K, Lernmark B, Lynch K, Breslow N, Lernmark Å. Diabetes Incidence Study in Sweden Group. Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15-35-year-old diabetic subjects. Journal of Diabetes and its Complications 2007;21(4):205-13 48. Jensen RA, Gilliam LK, Törn C, Landin-Olsson M, Palmer JP, Åkesson K Kockum I, Lernmark B, Karlsson AF, Lynch K, Breslow N, Lernmark Å. Diabetes Incidence Study in Sweden Group. Islet cell autoantibody levels after the diagnosis of young adult diabetic patients. Diabetic Medicine 2007;24(11):1221-8 49. Sedimbi SK, Luo XR, Sanjeevi CB on behalf of the Swedish Childhood Diabetes and Diabetes Incidence in Sweden Study Groups. SUMO4 M55V polymorphism affects susceptibility to type 1 diabetes in HLA DR3- and DR4-positive Swedish patients. Gene Immunity 2007;8:518-21 50. Shin J-H, Janer M, McNeney B, Blay S, Deutsch K, Sanjeevi CB, Kockum I, Lernmark Å, Graham J on behalf of the Swedish Childhood Diabetes and Diabetes Incidence in Sweden Study Groups. IA-2 autoantibodies in incident type 1 diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5. Genes Immunity 2007;8:503-12 51. Torffvit O, Eriksson JW, Henricsson M, Sundkvist G, Arnqvist HJ, Blohmé G, Bolinder J, Nyström L, Östman J, Svensson M. Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden. Journal of Diabetes and its complications. Journal of Diabetes and its Complications 2007;21:246-51 2008 52. Bakhtadze E, Cervin C, Lindholm E, Borg H, Nilsson P, Arnqvist HJ, Bolinder J, Eriksson JW, Gudbjörnsdottir S, Nyström L, Agardh C-D, Landin-Olsson M, Groop LC. Common variants in the TCF7L2 gene discriminate between autoimmune and non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients. Diabetologia 2008;51:2224-32 53. Östman J, Lönnberg G, Arnqvist HJ, Blohmé G, Bolinder J, Ekbom Schnell A, Eriksson JE, Gudbjörnsdottir S, Sundkvist G, Nyström L. Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden. Journal of Internal Medicine 2008;263:386-94 Accepted for publication: 54. Bakhtadze E, Cervin C, Lindholm E, Lyssenko V, Borg H, Nilsson P, Arnqvist HJ, Bolinder J, Eriksson JE, Gudbjörnsdottir S, Nyström L, Agardh C-D, Landin-Olsson M, Groop LC. Phenotypic effects of common variants in novel type 2 diabetes genes

in young and middle-aged patients with autoimmune and non-autoimmune diabetes. Journal of Clinical Endocrinology and Metabolism Submitted: 55. Bakhtadze E, Cervin C, Lindholm E, Lyssenko V, Borg H, Nilsson P, Arnqvist HJ, Bolinder J, Eriksson JE, Gudbjörnsdottir S, Nyström L, Agardh CC, Landin-Olsson M, Groop LC. Phenotypic effects of common variants in novel type 2 diabetes genes in young and middle-aged patients with autoimmune and non-autoimmune diabetes. Journal of Clinical Endocrinology and Metabolism Scientific publications published, in press or accepted for publication in international peer-reviewed journals (Swedish) 1986 1. Östman J, Schersten B. Vad orsakar diabetes mellitus. Läkartidningen 1986;83(35):2846-7 2. Lernmark Å, Östman J. Diabetes typ 1 med debut i åldrarna 15 till 34 år. Lägesrapport från diabetesincidensstudien i Sverige. Läkartidningen 1993,l90(42):3652-6